Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelli A Armstrong

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
ACS Chemical Biology|April 4, 2013
Development of an ALK2-biased BMP type I receptor kinase inhibitorAgustin H Mohedas, Xuechao Xing, Kelli A Armstrong, et al.
Molecular and Cellular Biology|April 11, 2013
Constitutively active ALK2 receptor mutants require type II receptor cooperationJana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Science Translational Medicine|November 25, 2016
Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossificationDevaveena Dey, Jana Bagarova, Sarah J Hatsell, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
ACS Chemical Biology|April 4, 2013
Development of an ALK2-biased BMP type I receptor kinase inhibitorAgustin H Mohedas, Xuechao Xing, Kelli A Armstrong, et al.
Molecular and Cellular Biology|April 11, 2013
Constitutively active ALK2 receptor mutants require type II receptor cooperationJana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Science Translational Medicine|November 25, 2016
Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossificationDevaveena Dey, Jana Bagarova, Sarah J Hatsell, et al.
Pageof 1